# Thermoacoustic Method for Estimating Liver Fat Fraction

> **NCT07321925** · — · RECRUITING · sponsor: **Endra Lifesciences** · enrollment: 49 (estimated)

## Conditions studied

- MASLD/MASH (Metabolic Dysfunction-Associated Steatotic Liver Disease / Metabolic Dysfunction-Associated Steatohepatitis)
- Fatty Liver Disease, Nonalcoholic

## Interventions

- **DEVICE:** Thermoacoustic Enhanced Ultrasound

## Key facts

- **NCT ID:** NCT07321925
- **Lead sponsor:** Endra Lifesciences
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** RECRUITING
- **Start date:** 2025-08-15
- **Primary completion:** 2025-10-30
- **Final completion:** 2025-12-31
- **Target enrollment:** 49 (ESTIMATED)
- **Last updated:** 2026-01-07


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07321925

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07321925, "Thermoacoustic Method for Estimating Liver Fat Fraction". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT07321925. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*